Prawo i regulacje · 01/08/2018

Galephar Pharmaceutical Research Inc. Files Application to Import Controlled Substances

Galephar Pharmaceutical Research Inc. has submitted an application to the U.S. government to import controlled substances, a process that requires regulatory approval from the Drug Enforcement Administration (DEA)